Try our Advanced Search for more refined results
Connecticut et al v. Sandoz, Inc. et al
Case Number:
3:20-cv-00802
Court:
Nature of Suit:
Judge:
Firms
- Skadden Arps
- Kelley Drye
- Saul Ewing
- Wilson Sonsini
- Debevoise & Plimpton
- Harris Beach Murtha Cullina PLLC
- Arnold & Porter
- Hogan Lovells
- Morrison & Foerster
- Baker Botts
- Wiggin & Dana
- Armstrong Teasdale
- Ropes & Gray
- K&L Gates
- Paul Hastings
- Dentons
- Barnes & Thornburg
- Faegre Drinker
- Cole Schotz
- Linklaters LLP
- Saxton & Stump
- Hinckley Allen
- Morgan Lewis
- Proskauer Rose
- Reed Smith
- DLA Piper
- Norton Rose
- Clifford Chance
- Troutman
- Mintz Levin
- Competition Law Partners
- O'Toole & O'Toole
- Shapiro Arato
- Shook Hardy
- Kasowitz LLP
- Bailey Duquette
- Petrillo Klein
- Day Pitney
- Dechert LLP
- Sperling Kenny
- Fine Kaplan
Companies
- Cencora Inc.
- Perrigo Co. PLC
- Lannett Company, Inc
- Bausch Health Cos. Inc.
- Sandoz International GmbH
- Aurobindo Pharma Ltd.
- Amneal Pharmaceuticals Inc.
- Lupin Ltd.
- Glenmark Pharmaceuticals Ltd.
- Viatris Inc.
- Allergan PLC
- Fougera Pharmaceuticals Inc.
- OptumRx Inc.
- G&W Laboratories Inc.
- Mallinckrodt PLC
- Optum Inc.
- Wockhardt USA LLC
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- U.S. District Court for the District of Columbia
- State of Indiana
- Commonwealth of Kentucky
- State of Nevada
- State of Tennessee
- State of Michigan
- Commonwealth of Massachusetts
Sectors & Industries:
-
December 19, 2024
Generic-Drug Cos. Get State AGs' Trial Order Flipped
A Connecticut federal court has sided with the generic-drug makers accused of price-fixing by state-level enforcers and will allow a narrower case involving 15 drugs to move ahead prior to a much broader case involving more than 100 medications.
-
December 18, 2024
State AGs, Generic Cos. Fight Over Price-Fixing Trial Order
A contingent of state-level enforcers told a Connecticut federal court there is no need to reconsider prioritizing a sprawling generic drug price-fixing case that involves more than 100 medications over a narrower case the drugmakers are asking to have tried first.
-
December 03, 2024
$1B Sandoz Placeholder Bid Needs More Support, Judge Says
A Connecticut federal judge on Tuesday said he cannot force Novartis spinoff Sandoz Inc. to set aside a $1 billion litigation placeholder in a generic drug pricing lawsuit without hearing whether the state attorney general can enforce possible orders in other states where the pharmaceutical company keeps assets.
-
November 13, 2024
Damages Limited In AGs' Generic Drug Price-Fixing Case
A Connecticut federal judge has nixed some claims against Sandoz Inc. and other generic-drug makers in a massive antitrust and unfair trade practices case filed by state attorneys general, finding that a handful of the enforcers cannot seek damages on behalf of their allegedly injured citizens.
-
October 31, 2024
Drug Cos. To Pay $49M For State-Led Generic Pricing Claims
A contingent of state-level enforcers reached settlements totaling $49.1 million on Thursday with Heritage Pharmaceuticals Inc. and Apotex Corp. for their alleged part in a wide-ranging conspiracy to inflate the price of generic drugs.
-
September 09, 2024
Generics Makers Want Mo. Sanctioned In Price-Fixing Case
Teva Pharmaceuticals Inc., Mylan Inc. and other generic-drug makers accused by state enforcers of fixing prices have urged a Connecticut federal judge to punish the state of Missouri for failing to provide information requested by the drug companies.
-
September 03, 2024
Louisiana Frees Aurobindo, Sandoz From Price-Fixing Suits
The state of Louisiana has dropped its remaining claims in three Connecticut-based lawsuits by a collection of state attorneys general against more than three dozen pharmaceutical companies alleging a generic drug price-fixing scheme, truncating assertions that accuse myriad drugmakers of Sherman Act violations.
-
July 01, 2024
State AGs Get Stay Lifted In Generic Drug Pricing Litigation
A Connecticut federal judge on Monday agreed to lift a partial discovery stay in a trio of generic drug pricing antitrust suits led by the attorneys general of New York and Connecticut, according to a short, text-only order posted to each of the case dockets.
-
June 27, 2024
State AGs Want Stay Lifted In Generic Drug Pricing Suit
The attorneys general of New York and Connecticut have asked a federal judge to lift a partial discovery stay in three state-led generic drug pricing lawsuits against the pharmaceutical industry, saying it is no longer necessary because sentencing is complete in a parallel U.S. Department of Justice proceeding.
-
June 04, 2024
HHS Guidance, Feud Over FCA Evidence, And A Deposed AG
States sue the Biden administration over nondiscrimination guidance. A False Claims Act case sees a tussle over evidence. A Connecticut federal judge allows drugmakers to depose the office of D.C.'s attorney general. Here, Law360 Healthcare Authority looks at notable developments in healthcare litigation over the past week.